title: TLR2 utilization of Borrelia does not induce p38- and IFN-beta autocrine loop-dependent expression of CD38, resulting in poor migration and weak IL-12 secretion of dendritic cells.
abstract: Lyme borreliosis is a tick-borne bacterial infection that in many cases is limited to the skin. However, in some patients the bacterium evades the immune response and disseminates into various organs. Dendritic cells (DCs) are among the first cells to meet invading pathogens in the skin. We have previously shown that CD38, an ectoenzyme involved in the migration of DCs and generally upregulated by microbial stimuli, is not upregulated in Borrelia garinii-stimulated DCs. In this paper, we characterize the cellular events that lead to the absence of CD38 on the DC surface after B. garinii stimulation and investigate the consequences of absent CD38 expression for the migration of DCs in vitro and in vivo. The data show that 1) effective signaling via p38 MAPK (and STAT1 and NF-kappaB) is needed for CD38 expression and 2) TLR2 stimulation, as opposed to TLR4 stimulation, does not induce IFN-beta autocrine loop-dependent expression of CD38 and secretion of IL-12. Further, we show that 3) B. garinii-stimulated DCs do not migrate effectively toward CCL19 and CCL21 and 4) after B. garinii infection of mice, the number of DCs migrating from the infection site to draining lymph nodes is only half that induced by Escherichia coli infection. Our results provide evidence for the first time that different TLR use results in different CD38 expression, which correlates with the migratory potential of DCs.
authors.affiliation: Department of Medical Microbiology and Immunology, University of Turku, Finland. pauliina.hartiala@utu.fi
authors.forename: Pauliina
authors.initials: P
authors.lastname: Hartiala
authors.forename: Jukka
authors.initials: J
authors.lastname: Hytönen
authors.forename: Heta
authors.initials: H
authors.lastname: Yrjänäinen
authors.forename: Maria
authors.initials: M
authors.lastname: Honkinen
authors.forename: Perttu
authors.initials: P
authors.lastname: Terho
authors.forename: Mirva
authors.initials: M
authors.lastname: Söderström
authors.forename: Markus A
authors.initials: MA
authors.lastname: Penttinen
authors.forename: Matti K
authors.initials: MK
authors.lastname: Viljanen
mesh_terms: D051997:ADP-ribosyl Cyclase 1 / Q000096:biosynthesis / Q000172:deficiency; D000818:Animals; D019898:Autocrine Communication / Q000276:immunology; D015748:Borrelia burgdorferi Group / Q000276:immunology*; D002465:Cell Movement / Q000276:immunology; D002478:Cells, Cultured; D003713:Dendritic Cells / Q000276:immunology* / Q000378:metabolism; D004926:Escherichia coli / Q000276:immunology; D006801:Humans; D016899:Interferon-beta / Q000502:physiology; D018664:Interleukin-12 / Q000378:metabolism; D008070:Lipopolysaccharides / Q000502:physiology; D008562:Membrane Glycoproteins / Q000096:biosynthesis / Q000172:deficiency; D051379:Mice; D008807:Mice, Inbred BALB C; D051195:Toll-Like Receptor 2 / Q000378:metabolism* / Q000502:physiology; D048051:p38 Mitogen-Activated Protein Kinases / Q000096:biosynthesis / Q000502:physiology
chemical_list: D008070:Lipopolysaccharides; D008562:Membrane Glycoproteins; C495342:TLR2 protein, human; C493486:Tlr2 protein, mouse; D051195:Toll-Like Receptor 2; D018664:Interleukin-12; D016899:Interferon-beta; D048051:p38 Mitogen-Activated Protein Kinases; C498154:CD38 protein, human; C498155:Cd38 protein, mouse; D051997:ADP-ribosyl Cyclase 1